期刊文献+

熊去氧胆酸与思美泰治疗妊娠期肝内胆汁瘀积症的疗效观察 被引量:2

熊去氧胆酸与思美泰治疗妊娠期肝内胆汁瘀积症的疗效观察
下载PDF
导出
摘要 目的:观察熊脱氧胆酸(UD-CA)、思美泰(SAMe)治疗妊娠期肝内胆汁淤积症(ICP)的效果。方法:选择60例ICP患者,随机分成二组:A组采用UDCA口服,300mg/次,2次/d;B组采用SAMe1000mg静滴,1次/d;治疗3周或至分娩止,比较二组患者的疗效。结果:治疗后所有患者瘙痒症状改善,两组瘙痒评分差异无显著性意义(P>0.05);治疗后血清T:BA、TB、ALT和AST的水平明显降低(P<0.01),A组的水平较B纽下降明显,差异有显著性意义(P<0.05)。两组妊娠结局差异无显著性意义(P>0.05)。结论:治疗妊娠期肝内胆汁瘀积症,熊去氧胆酸对胆酸及肝功指标的改善较思美泰有效,两种治疗方法均对瘙痒症状改善有效。 Objective to observe the efficacy of ursodeoxychol ic acid (UDCA) , S - ade- nosy - L - methionine (SAMe) in the treatment of intrahepatic cholestasis of pregnancy. Methods: 60 patients were randomly divided into two groups:Group A receiving oral UDCA 300mg,bi/d and group B receiving SAMe 1000mg, q/d. The symptom of itching and serum biochemical indexes, including TBA, TB, ALT, and AST were observed after 3 weeks treatment or deliveried, and the pregnancy outcome between the two groups was compared after delivery. Results: All the patients had a significant improvement in pruritus, There were no significant diferenees among the skin pruritus score in two groups. TBA, ALT, AST and TB had a obvious reduce ( P 〈 0.0 1 ). It was significantly lower in group A than Group B ( P 〈 0. 05). The pregnancy outcome between the two groups was similar( P 〉 0. 05 ). Conclusions In women with intrahepatic cholestasis of pregnancy, ursodeoxycholic acid is more effective than S - adenosyl - L - methionine at improving the concentration of serum bile acids and other tests of liver function, whereas both therapies are equally effective at improving pruritus.
作者 张玲珍
出处 《中国社区医师(医学专业)》 2009年第1期37-38,共2页
关键词 妊娠期肝内胆汁瘀积症 熊去氧胆酸 思美泰 Intrahepatic Cholestasis of Pregnancy ( ICP ) ursodeoxycholic acid ( UD-CA) S - adenosy - L - methionine(SAMe)
  • 相关文献

参考文献2

二级参考文献43

  • 1刘伯宁 沈宁 等.妊娠期肝内胆汁淤积症胎盘的组织计量测定[J].中华妇产科杂志,1988,23:9-12.
  • 2曹泽毅.《中华妇产科学》[M](第1版)[M].北京:人民卫生出版社,1999.500-507.
  • 3Frezza M, Surrenti C, ManziUo G, Fiaccadori F, Bortolini M, Di Padova C, Oral S.adenosylmethionine in the symptomatic treatment of mtrahepatic cholestasis. A double-blind, placebo-controlled study[J]. Gastroenterology, 1990; 99(1 ) : 211 - 215.
  • 4Alma.rio P, Bortolini M, Pagliaro L, Coltorti M. Role of S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis [J ]. Drugs,1990; 40 (Suppl 3) : 111-123.
  • 5Jadad AR, Moore A, Carroll D. Assessing the quality of reports ofrandomized chnical trials: Is bhnding necessary [ J ]. Control Clinical Trials, 1996; 17(1): 1-12.
  • 6Bonessio L, Ciardo A, Spina V, Morini A. Intrahepatic cholestasis in pregnancy[J]. Clin Ter, 1996; 147(7-8) : 377 -384.
  • 7Ribalta J, Reyes H, Gonzalez MC. S-adenosyl-L-methionine in the treatment of patients with intrahepatic cholestasis of pregnancy: a randomized, double-blind, placebo-controlled study with negative results[J]. Hepatology, 1991; 13(6): 1 084-1 089.
  • 8Frezza M, Pozzato G, Chiesa L. Reversal of intrahepatic cholestasis of pregnancy in women after high dose S-adenosyl-L-methioninead ministration[J]. Hepatology, 1984; 4(2): 274-278.
  • 9Floreani A, Patemoster D, Melis A, Grella PV. S-adenosyl-1-methionine versus ursodeox-ycholic acid in the treatment of intrahepatic cholestasis of pregnancy: preliminary results of a controlled trial[ J ], Eur J Obstet Gynecol Reprod Biol, 1996 ;67 ( 2 ) :109 - 113.
  • 10Frezza M, Tritapepe R, Pozzato G, Di Padova C. Prevention of S-adenosyl-l-methionine of estrogen-induced hepatobiliary toxicity in susceptible women[J]. Am J C, astroenterol,1988; 83(10) : 1 098 -1102.

共引文献58

同被引文献14

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部